Exosomes Mediated Transfer of Circ_UBE2D2 Enhances the Resistance of Breast Cancer to Tamoxifen by Binding to MiR-200a-3p
Overview
Pathology
Affiliations
BACKGROUND Circular RNA UBE2D2 (circ_UBE2D2) has been found to be involved in the progression of breast cancer. Exosomes are critical mediators of intercellular communication, however, the function of exosomal circ_UBE2D2 in breast cancer remains vague. MATERIAL AND METHODS Cell viability was measured by Cell Counting Kit-8 assay. Western blot was used to detect the levels of estrogen receptor alpha (ERalpha), E-cadherin, vimentin, CD9, and CD63. Migrated and invaded cells were examined using Transwell assay. Circ_UBE2D2 and microRNA (miR)-200a-3p levels were detected using quantitative real-time polymerase chain reaction. Exosomes were isolated by ultracentrifugation method. The interaction between circ_UBE2D2 and miR-200a-3p was confirmed by dual-luciferase reporter assay and RNA immunoprecipitation assay. Murine xenograft model was established to conduct in vivo experiments. RESULTS We found that circ_UBE2D2 was upregulated in breast cancer tamoxifen-resistant tissues and cell lines, and circ_UBE2D2 deletion mitigated tamoxifen resistance in breast cancer cells. Circ_UBE2D2 was also significantly loaded in exosomes isolated from resistant cells and could be transferred to parental cells. MiR-200a-3p was a target of circ_UBE2D2, and we demonstrated that exosomes mediated transfer of circ_UBE2D2 interacted with miR-200a-3p to enhance tamoxifen resistance of breast cancer cells by regulating cell viability, metastasis, and the level of ERalpha in vivo and in vitro. CONCLUSIONS Exosomes mediated transfer of circ_UBE2D2 reinforced tamoxifen resistance in breast cancer by binding to miR-200a-3p, providing new insights into the boost of the effectiveness of tamoxifen on breast cancer patients.
Exosomal circRNAs: Deciphering the novel drug resistance roles in cancer therapy.
Li X, Liu H, Xing P, Li T, Fang Y, Chen S J Pharm Anal. 2025; 15(2):101067.
PMID: 39957900 PMC: 11830318. DOI: 10.1016/j.jpha.2024.101067.
Extracellular Vesicles as Mediators and Potential Targets in Combating Cancer Drug Resistance.
Zhang H, Wu B, Wang Y, Du H, Fang L Molecules. 2025; 30(3).
PMID: 39942602 PMC: 11819960. DOI: 10.3390/molecules30030498.
The role of circRNA in breast cancer drug resistance.
Yang S, Li D PeerJ. 2024; 12:e18733.
PMID: 39713143 PMC: 11662897. DOI: 10.7717/peerj.18733.
Development and validation of disulfidptosis-related genes signature for patients with glioma.
Wang J, Luo J, Yang S, Deng Y, Chen P, Tan Y Discov Oncol. 2024; 15(1):758.
PMID: 39692962 PMC: 11655816. DOI: 10.1007/s12672-024-01664-z.
Martinez-Rodriguez A, Fuentes-Antras J, Lorca V, Lopez de Sa A, Perez-Segura P, Moreno F Int J Mol Sci. 2024; 25(23).
PMID: 39684756 PMC: 11641624. DOI: 10.3390/ijms252313045.